Pathophysiology and Treatment of Cerebrospinal Hypotension Exploration Study
Launched by DANISH HEADACHE CENTER · Jan 28, 2025
Trial Information
Current as of July 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria (patients):
- • Age 18-80.
- • Patients with a suspected intracranial hypotension diagnosis.
- • Participants must read and understand the Danish language or have an official interpreter present to be able to understand the work-up and sign the participation consent for the study.
- Inclusion Criteria (Control):
- • Age 18-80.
- • Healthy people who do not suffer from any form of primary headache except infrequent tension-type headache.
- • Participants must read and understand the Danish language or have an official interpreter present to be able to sign the participation consent for the study.
- Exclusion Criteria (patients):
- • Pregnant or breastfeeding females
- • Patients in whom the examination cannot be performed due to anatomical reasons such as severe head dysmorphia or severe ophthalmological diseases.
- • The patient has a disease, takes medication, or abuses alcohol or drugs that could, in the investigator´s opinion interfere with the assessments of safety, tolerability, or efficacy, or interfere with the conduct or interpretation of the study.
- • The patient is, in the investigator´s opinion, unlikely to comply with the protocol or is unsuitable for any reason.
- Exclusion Criteria (Control):
- • Pregnant or breastfeeding females
- • Participants in whom the examination cannot be performed due to anatomical reasons such as severe head dysmorphia or severe ophthalmological diseases.
- • The participant has a disease, takes medication, or abuses alcohol or drugs that could, in the investigator´s opinion interfere with the interpretation of the study.
About Danish Headache Center
The Danish Headache Center is a leading research institution dedicated to advancing the understanding and treatment of headache disorders. As a prominent clinical trial sponsor, the center focuses on innovative therapeutic approaches and comprehensive patient care, aiming to improve the quality of life for individuals suffering from various types of headaches, including migraines and tension-type headaches. With a multidisciplinary team of experts in neurology, psychology, and pain management, the Danish Headache Center is committed to conducting rigorous clinical trials that contribute to evidence-based practices and the development of novel interventions in headache research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Glostrup, Copenhagen, Denmark
Patients applied
Trial Officials
Henrik W Schytz, MD, Ph.D. DMSc
Principal Investigator
Danish Headache Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported